Senior Manager, Medical Affairs

Aeira Pte. Ltd.; Santo Niño 1st; Hybrid; PHP 7,524,000 - 11,285,000; Full time

Job summary

Aeira is seeking a Senior Manager, Medical Affairs to lead regional medical strategy and execution across SEA. You will own scientific engagement, KOL networks and evidence-generation programmes that support product adoption and market development.

The role collaborates with the VP Strategy & Market Access and leadership to shape the regional medical presence, while building a scalable MSL function and advancing IITs, RWE and pre-launch activities.

Qualifications

• 8+ years in Medical Affairs or related field.
• MD/PhD/PharmD or equivalent preferred.
• Experience with SEA markets and KOL networks.
• Experience with IITs, RWE and advisory boards.
• Willingness to travel across SEA markets.

Responsibilities

• Develop regional medical strategies aligned with product lifecycle and clinical evidence.
• Partner with Commercial, Market Access and Regulatory teams for country medical launch plans.
• Build and manage KOL/hcp engagement across SEA markets.
• Lead scientific education programmes, advisory boards and IITs.
• Oversee collection and communication of insights from KOLs and clinicians.
• Provide medical oversight for NPPs, early-access and pre-launch activities.
• Support creation of medical materials and responses to inquiries.

Skills

KOL engagement

Advisory boards

RWE

Early access / NPP

Scientific communication

Executive presentation

Autonomy with leadership

Travel across SEA

Education

MD/PhD/PharmD or equivalent

Job description

About the role

The Senior Manager, Medical Affairs leads regional medical strategy and execution for Aeira's portfolio. This role owns scientific engagement, KOL networks and evidence-generation programmes that support product adoption, appropriate use and long-term market development across SEA. This role plays a key part in shaping the regional medical presence — working closely with the VP, Strategy & Market Access and wider leadership team on KOL engagement, evidence strategy and scientific engagement, as the team and portfolio grow.

Key responsibilities

• Develop regional medical strategies aligned with product lifecycle, clinical evidence, regulatory and commercialization plans.
• Partner with Commercial, Market Access and Regulatory teams to build country-specific medical launch plans and ensure scientific readiness ahead of launch.
• Maintain working familiarity with key hospital and account dynamics that inform medical engagement planning.
• Identify, map and build relationships with key opinion leaders, clinical experts and scientific societies across SEA.
• Personally lead field-based KOL and HCP engagement across SEA markets, with the expectation of helping build and, over time, oversee a regional MSL team as the function scales.
• Develop and oversee scientific education programmes, advisory boards, symposia and other non-promotional medical activities.
• Establish structured mechanisms to collect, analyze and communicate insights from KOLs, HCPs and the clinical community to inform strategy.
• Identify and lead IITs, RWE, registries and other local evidence-generation programmes to address clinical and market-access evidence gaps.
• Provide medical oversight for Named Patient Programmes, early/special-access programmes and pre-launch activities.
• Support development and review of medical/scientific materials, publications, congress activities and responses to unsolicited medical enquiries.

About you

• 8+ years in Medical Affairs, clinical development or medical strategy within pharmaceutical or biotech companies, including experience managing scientific engagement independently or with minimal oversight.
• Medical or scientific background — MD, PharmD, PhD or equivalent preferred.
• Experience with innovative medicines/biologics, ideally in specialty care, immunology, oncology or other hospital/specialist-driven products.
• Strong understanding of SEA healthcare systems and clinical/KOL networks; familiarity with regulatory/HTA bodies across SEA markets is a plus.
• Demonstrated experience in KOL engagement, advisory boards, IITs and/or RWE.
• Experience supporting NPP, early-access or pre-launch programmes is highly desirable.
• Comfort contributing to medical affairs processes and structures in a lean, early-stage environment.
• Strong scientific communication and executive presentation capabilities, with a track record of building trust with KOLs, HCPs and internal leadership quickly.
• Sound judgment and comfort operating with a degree of autonomy, while working closely with leadership as the regional medical function develops.
• Willingness to travel across SEA markets for KOL and HCP engagement.

About us

Aeira is a global pharmaceutical company focused on bringing innovative medicines to patients with unmet medical needs, and improving the global accessibility and affordability of innovative medicines. Aeira carries breakthrough science — wherever it originates — through the commercial, regulatory and market-access work that turns a molecule into a medicine a patient can actually receive. Everything we do is guided by three principles: Continuity in healing. Connection through science. Care without borders.

WHY AEIRA, WHY NOW

• Impact from day one, not just execution. The QMS and initial PV framework you build become part of the foundation the company's compliance is built on — in close partnership with the VP and leadership team.
• International, flat team — an open communication culture where you can share ideas directly with leadership, without layers of approval.
• Direct mentorship from the VP and wider leadership team, with a clear path for career progression as the function and portfolio grow.
• Cutting-edge exposure across oncology, immunology and metabolic disease — staying close to the latest innovative pipelines coming out of China.
• Room to grow beyond core QA skills — into in-licensing evaluation, overseas market commercialization, and real deal execution as Aeira's regional footprint expands.